论文部分内容阅读
目的:探究分析甲氨蝶呤配伍非司酮治疗输卵管妊娠的临床价值。方法:收集于2014年6月~2015年9月在我院就诊的80例输卵管妊娠的患者,将其随机分为对照组和治疗组两组,各40例。对照组患者单纯使用米非司酮治疗,治疗组患者采用甲氨蝶呤配伍米非司酮的方案进行治疗,比较两组患者的有效率。结果:经过治疗,治疗组显效10例,对照组显效4例,治疗组的显效例数明显较对照组高(p<0.05),差异具有统计学意义;治疗组总有效率95%,对照组总有效率80%,治疗组亦显著高于对照组(p<0.05),差异具有统计学意义。结论:甲氨蝶呤配伍米非司酮治疗输卵管妊娠的效果良好,临床价值较高,值得推广。
Objective: To investigate the clinical value of methotrexate and metformin in the treatment of tubal pregnancy. Methods: Eighty patients with tubal pregnancy treated in our hospital from June 2014 to September 2015 were randomly divided into control group and treatment group, 40 cases in each group. Patients in the control group were treated with mifepristone only. Patients in the treatment group were treated with methotrexate in combination with mifepristone, and the efficiency of the two groups was compared. Results: After treatment, the treatment group markedly effective in 10 cases, the control group markedly effective in 4 cases, the treatment group significantly more effective than the control group (p <0.05), the difference was statistically significant; the total effective rate was 95% in the control group The total effective rate was 80%, the treatment group was also significantly higher than the control group (p <0.05), the difference was statistically significant. Conclusion: The combination of methotrexate and mifepristone has a good effect on tubal pregnancy, and its clinical value is high and worthy of promotion.